1)Mack MJ, Leon MB, Thourani VH ; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med 2019 ; 380 : 1695-705.
2)Izumi C, Eishi K, Ashihara K, et al. JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease. Circ J 2020 ; 84 : 2037-119.
3)Handa N, Kumamaru H, Torikai K, et al. Learning Curve for Transcatheter Aortic Valve Implantation Under a Controlled Introduction System-Initial Analysis of a Japanese Nationwide Registry. Circ J 2018 ; 82 : 1951-8.
4)Yamamoto M, Watanabe Y, Tada N, et al. Transcatheter aortic valve replacement outcomes in Japan : Optimized CathEter vAlvular iNtervention(OCEAN)Japanese multicenter registry. Cardiovasc Revasc Med 2019 ; 20 : 843-51.
5)Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease : Executive Summary : A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021 ; 143 : e35-e71.
6)Vahanian A, Beyersdorf F, Praz F, et al ; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022 ; 43 : 561-632.
7)Landes U, Webb JG, De Backer O, et al. Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction. J Am Coll Cardiol 2020 ; 75 : 1882-93.
8)Stone GW, Lindenfeld J, Abraham WT, et al ; COAPT Investigators. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 2018 ; 379 : 2307-18.
Treatment in a Japanese Cohort. Circ J 2017 ; 81 : 1116-22.